Abstract 55: TT-702, a selective and potent A2B receptor antagonist for the treatment of cancer

Authors: Peidong Fan, Filomena Housley, Helena Haberstock, Ken Horne, Jim Liu, Elfatih Elzein, Lina Yao

Published: 2021-07-01

DOI: 10.1158/1538-7445.am2021-55

Source: Full article